Innovative therapies utilizing pepducins to modulate G-protein receptors, thereby expanding treatments for cancer, diabetes, inflammation, and regenerative medicine
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Anchor Therapeutics plus 4809 other startups.
